Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on transforming healthcare. It invests across therapeutic areas including immunology, oncology, rare diseases, vaccines, and data science.
49% of their portfolio is in Biotech & Life Sciences. Deal activity increased 125% year-over-year (18 deals in the last 12 months). Their most common stage is series-b (40% of deals). Average disclosed round size is $99.7M (across 83 rounds with reported amounts).
Portfolio
80
Fund Size
$625M
Top Stage
Series B
Last 12 Mo
13
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
90 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 BranchLab | Unknown | $26M | May 2026 |
| AAltesa Biosciences | Series B | $75M | Feb 2026 |
 QuantX Biosciences | Series B | $85M | Feb 2026 |
| QQuantX | Series B | $85M | Feb 2026 |
 Alveus Therapeutics | Series A | $160M | Jan 2026 |
 Enable Injections | Unknown | $30M | Jan 2026 |
| BranchLab | Series A | $26M | Jan 2026 |
 Memento Medicines | Series A | $93M | Jan 2026 |
| IInduPro Therapeutics | Unknown | — | Dec 2025 |
 Lifordi Immunotherapeutics | Unknown | — | Nov 2025 |
 Zag Bio | Series A | $80M | Oct 2025 |
 Electra | Series C | $183M | Oct 2025 |
| EElectra Therapeutics | Series C | $183M | Oct 2025 |
 MapLight Therapeutics | Series D | $372.5M | Jul 2025 |
| SSAB Biotherapeutics, Inc. | Series B | $175M | Jul 2025 |
 SpliceBio | Series B | $135M | Jun 2025 |
| SSplice Bio | Series B | $135M | Jun 2025 |
| TTherini Bio | Series A | $39M | May 2025 |
 Zucara Therapeutics | Series B | $25M | May 2025 |
 Granite Bio | Series B | $70M | Apr 2025 |
 Attovia Therapeutics | Series C | $90M | Apr 2025 |
 Latigo Biotherapeutics | Series B | $150M | Mar 2025 |
 Curevo | Series B | $110M | Mar 2025 |
| AAbcuro, Inc. | Series C | $200M | Feb 2025 |
 Atalanta Therapeutics | Series B | $75M | Jan 2025 |
Page 1 of 4
Top Co-Investors
RA Capital Management15 shared
Cormorant Asset Management11 shared
OrbiMed10 shared
Alexandria Venture Investments9 shared
Redmile Group8 shared
Forbion8 shared
Novo Capital8 shared
EQT Life Sciences7 shared
Sofinnova Partners7 shared
New Enterprise Associates6 shared
Amgen Ventures6 shared
Samsara BioCapital6 shared
Blue Owl Capital5 shared
New Leaf Venture Partners5 shared
Frazier Life Sciences5 shared
Atlas Venture5 shared
ARCH Venture Partners5 shared
Dementia Discovery Fund5 shared
SV Health Investors5 shared
Abingworth LLP5 shared
Last updated: 7 September 2026